Gastroesophageal Reflux Disease Market 2024-2034
                     Gastroesophageal 
Reflux Disease 
Market Research 
Report 2024-2034
ABOUT IMARC
International Market Analysis Research and 
Consulting Group is a leading adviser on 
management strategy and market research 
worldwide. We partner with clients in all regions and 
industry verticals to identify their highest-value 
opportunities, address their most critical challenges, 
and transform their businesses.
IMARC’s information products include major market, 
scientific, economic and technological developments 
for business leaders in pharmaceutical, industrial, 
and high technology organizations. Market forecasts 
and industry analysis for biotechnology, advanced 
materials, chemicals, food and beverage, travel and 
tourism, nanotechnology and novel processing 
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable 
insight into the dynamics of companies and markets 
with close cooperation at all levels of the client 
organization. This ensures that our clients achieve2 
unmatchable competitive advantage, build more 
proficient organizations, and secure lasting results.
Report Description and Highlights
Gastroesophageal Reflux Disease Market Report Overview:
• Report Attribute Details
• Base Year                   2023
• Forecast Years 2024-2034
• Historical Years 2018-2023
• Market Growth (2024-2034) 1.21%
The report offers a comprehensive analysis of the Gastroesophageal Reflux Disease market in the United States, EU5 (including Germany, 
Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in 
development, the proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report 
evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key 
markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and 
anyone interested or involved in the Gastroesophageal Reflux Disease market.
3
Report Description and Highlights
Market Overview:
The 7 major gastroesophageal reflux disease markets are expected to exhibit a CAGR of 1.21% during 2024-
2034. Gastroesophageal reflux disease (GERD) refers to a common and chronic condition indicated by 
recurring episodes of stomach acid refluxing or supporting up into the esophagus, the connecting tube 
between the throat and abdomen. The gastroesophageal reflux disease market is currently experiencing 
significant expansion, driven by a combination of influential factors. A major contributor to market growth is 
the escalating prevalence of GERD. Sedentary lifestyles, poor dietary choices, and obesity collectively 
contribute to the rise in gastroesophageal reflux disease cases, creating a heightened demand for effective 
treatment options. Advancements in diagnostic methods, including endoscopy, pH monitoring systems, and 
esophageal impedance monitoring, enable healthcare professionals to make more precise diagnoses, thereby 
augmenting the need for these diagnostic tools. Greater awareness of GERD and its associated symptoms has 
emerged, with an increased focus on public health and overall well-being. Patients are now more informed and 
proactive in seeking medical advice, resulting in early detection and prompt initiation of treatment.
4
Pharmaceutical companies continuously innovate a range of therapies, from over-the-counter antacids to 
prescription-based proton pump inhibitors (PPIs) and surgical procedures. 
Report Description and Highlights
This diverse therapeutic landscape provides healthcare providers with a broader array of options to address 
various levels of GERD severity. Considering the heightened susceptibility of older individuals, the aging 
population is expected to contribute to the increased prevalence of gastroesophageal reflux in the foreseeable 
future. Substantial investments in research and development efforts drive the exploration of innovative 
medication approaches, including alternative medications, non-invasive interventions, and personalized 
treatments tailored to individual patient profiles. Moreover, the integration of digital health technologies, 
telemedicine, and wearable devices for symptom monitoring facilitates the remote tracking and management 
of gastroesophageal reflux patients, effectively accelerating the growth trajectory of the market in the coming 
years.
Request a Sample Report: 
https://www.imarcgroup.com/gastroesophageal-reflux-disease-market/requestsample
5
Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2034
Countries Included:
• United States
• Germany
• France
6
Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Gastroesophageal Reflux Disease market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Gastroesophageal Reflux Disease market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current Gastroesophageal Reflux Disease 
marketed drugs and late-stage pipeline drugs.
7
Report Description and Highlights
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
View Report TOC, Figures and Tables: https://www.imarcgroup.com/gastroesophageal-reflux-disease-market
8
Report Description and Highlights
Competitive Landscape With Key Players:
The competitive landscape of the Gastroesophageal Reflux Disease market has been studied in the report with 
the detailed profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: 
https://www.imarcgroup.com/request?type=report&id=8331&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as 
a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research 
worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, 
address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for 
business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and 
industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and 
tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 9
Report Description and Highlights
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: [email protected]
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/
1
0
Key Questions Answered in the Report
1. How has the Gastroesophageal Reflux Disease market performed so far and how will it perform in the 
coming years?
2. What are the markets shares of various therapeutic segments in 2023 and how are they expected to 
perform till 2034?
3. What was the country-wise size of the Gastroesophageal Reflux Disease market across the seven major 
markets in 2023 and what will it look like in 2034?
4. What is the growth rate of the Gastroesophageal Reflux Disease market across the seven major markets 
and what will be the expected growth over the next ten years?
5. What are the key unmet needs in the market?
11
Table of 
Contents
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
13
Table of Contents
4 Gastroesophageal Reflux Disease - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2018-2023) and Forecast (2024-2034)
4.4 Market Overview (2018-2023) and Forecast (2024-2034)
4.5 Competitive Intelligence
5 Gastroesophageal Reflux Disease - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
    
Click here to visit the complete table of content with list of figures and tables: 
https://www.imarcgroup.com/gastroesophageal-reflux-disease-market/toc
14
Partial List Of Our Clients
15
OUR CLIENTS
16
Disclaimer
© 2024 IMARC All Rights Reserved 
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of 
International Market Analysis Research and Consulting (IMARC). No part of this publication may be 
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be 
used in any form or by and means graphic electronic or mechanical, including photocopying, recording, 
taping or by information storage or retrieval, or by any other form, without the express consent of 
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion 
have been based on information and sources believed to be accurate and reliable at the time of 
publishing. International Market Analysis Research and Consulting makes no representation of warranty 
of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability 
whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this 
publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International 
Market Analysis Research and Consulting. All other trademarks used in this publication are registered 
1
trademarks of their respective companies. 7